ArticleScientific reports2026
Scalable risk stratification of undiagnosed heart failure using routine health data and its association with imaging phenotypes and outcomes.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Late diagnosis of Heart failure (HF) is associated with worse outcomes. We aimed to develop a scalable tool to identify those at high risk of undiagnosed HF using routine electronic health records (EHR). We developed and internally validated a logistic regression (FIND-HF) model for incident HF diagnosis within one year in United Kingdom primary care EHRs (CPRD-Aurum, n=3 520 186), with good prediction performance (area under the receiver operating characteristic curve (AUC) 0.79), equal to more complex modelling techniques. We externally validated FIND-HF in United Kingdom (CPRD-GOLD, n=570 850, AUC 0.72), Japan (JMDC, n=6 820 694, AUC 0.73), United States of America (Epic Cosmos, n=7 710 398, AUC 0.78), and Taiwan (NTUH, n=170 518, AUC 0.85). In a cohort who had undergone HF diagnostics an optimised FIND-HF threshold had a positive predictive value of 21.4% and a negative predictive value of 96.9%. Amongst patients with HF who had undergone cardiac magnetic resonance imaging, high FIND-HF risk compared with low FIND-HF risk as reference, was associated with increased risk of a primary composite outcome of heart failure hospitalisation or cardiovascular death and more advanced adverse remodelling including lower left ventricular ejection fraction. FIND-HF is a scalable EHR-based model which has the potential to help rule out undiagnosed HF in low risk cases, whilst high risk cases are associated with more advanced cardiac dysfunction and worse prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.